Jim Hollingshead

2021

In 2021, Jim Hollingshead earned a total compensation of $4.3M as President – sleep and respiratory care business at ResMed, a 28% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$681,378
Salary$707,000
Stock Awards$2,900,000
Other$38,248
Total$4,326,626

Hollingshead received $2.9M in stock awards, accounting for 67% of the total pay in 2021.

Hollingshead also received $681.4K in non-equity incentive plan, $707K in salary and $38.2K in other compensation.

Rankings

In 2021, Jim Hollingshead's compensation ranked 3,065th out of 12,405 executives tracked by ExecPay. In other words, Hollingshead earned more than 75.3% of executives.

ClassificationRankingPercentile
All
3,065
out of 12,405
75th
Division
Manufacturing
1,224
out of 5,494
78th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
141
out of 798
82nd
Industry group
Surgical, Medical, And Dental Instruments And Supplies
90
out of 519
83rd
Industry
Surgical and Medical Instruments and Apparatus
60
out of 324
82nd
Source: SEC filing on October 5, 2022.

Hollingshead's colleagues

We found three more compensation records of executives who worked with Jim Hollingshead at ResMed in 2021.

2021

Michael Farrell

ResMed

Chief Executive Officer

2021

Rob Douglas

ResMed

Chief Operating Officer

2021

Brett Sandercock

ResMed

Chief Financial Officer

News

You may also like